Results 171 to 180 of about 168,320 (317)

Tailored immunotherapy for HPV positive head and neck squamous cell cancer

, 2013
Neil Gildener‐Leapman, John Lee, Robert L. Ferris   +2 more
openalex   +2 more sources

Two‐Dimensional Materials For Lateral Flow Assays: A Critical Review of Functional Roles and Translational Challenges

VIEW, EarlyView.
2D nanosheets, with large surface area, excellent optical/electrical properties, and high specificity, combine with lateral flow assay strips to enable rapid, readable detection, boosting the strips’ development and applications. Abstract Lateral flow assays (LFAs) are widely used for point‐of‐care diagnostics, but their detection capability remains ...
Weimin Xu, Ruping Liu, Na Gao, Jianxiao Zhu, Haowen Jiang, Shouzheng Jiao, Zhicheng Sun, Kai Shen, Gaolian Xu, Minghua Du, Ziyan Li, Yang Wang   +11 more
wiley   +1 more source

Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo. [PDF]

PLoS One
Neema Ufoy Mungu Y, Desreux J, Bianchi E, Junior BL, Djang'eing'a RM, Keith D, Maria A, Bosunga K, Bours V.   +8 more
europepmc   +1 more source

Facility Type Predicts Treatment Regimen for Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objectives Treatment landscapes are changing for HPV+ oropharyngeal cancer (OPC) without compromising oncologic outcomes. We aim to analyze treatment trends of HPV+ OPC at academic (ACs) and nonacademic centers (NACs). Methods The National Cancer Database was queried, and multinomial logistic regression was used to predict treatment trends ...
Monica S. Trent, Kelsey Roman, Timothy I. Hsu, Yarah M. Haidar, Tjoson Tjoa   +4 more
wiley   +1 more source

Comparison of self-collected vaginal swabs and first-void urine for detection of human papillomavirus in sexually active girls and women in three South Asian countries. [PDF]

PLoS One
Telele N, Katuwal N, Kabir F, Rahman S, Shahi SB, Yadav RR, Aziz F, Hossain MA, Hill AM, Permatasari I, Lee Y, Cho H, Lee J, You YA, Ahn HS, Park S, Tamrakar D, Pasha A, Alam A, Rahman FN, Shiblee S, Ejaz M, Nisar MI, Querec TD, Lawal BJ, Choi EM, Watson-Jones D, Basnet P, Uranw S, Shrestha R, Shrestha A, Jehan F, Nahar Q, Hotwani A, Rahman M, Lynch JA, Unger ER.   +36 more
europepmc   +1 more source

Induction of Apoptosis by Cidofovir in Human Papillomavirus (HPV)-Positive Cells

, 2001
Graciela Andreï, Robert Snoeck, Dominique Schols, Erik De Clercq   +3 more
openalex   +1 more source

Inflammatory Markers‐Based Surgical Pathological Complete Response Prediction After Neoadjuvant Immunotherapy Combined With Chemotherapy in Head and Neck Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To explore the predictive value of blood routine parameters for surgical pathological complete response (PCR) following neoadjuvant immunotherapy combined with chemotherapy (NICC) in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Yu‐Dong Ning, Yi‐Xuan Song, Han Li, Yu‐Qin He, Shao‐Yan Liu   +4 more
wiley   +1 more source

Oral human papillomavirus infection aligns with a coordinated bacterial microbiome inferred virulence ecology. [PDF]

Front Cell Infect Microbiol
Chambuso R, Alajrami S, Wali Jan N, Allam M, Desai V, Mohamed YS, Al-Marzooq F.   +6 more
europepmc   +1 more source

CD4+Foxp3+CD127+low T-Regulatory Cells are Increased in HPV Infected Papillomas in Patients with Recurrent Respiratory Papillomatosis (RRP) [PDF]

, 2008
Lynda Hatam, David Rosenthal, James A. DeVoti, Fung Lam, A. L. Abramson, Bettie M. Steinberg, Vincent R. Bonagura   +6 more
openalex   +1 more source

Biomarkers Predictive of Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma: Current Insights and Future Perspectives

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan, Zhao‐Hong An, Chang‐Ming An   +2 more
wiley   +1 more source